Open Access
Open access
American Medical Association (AMA)
JAMA Dermatology
,  volume 161 ,  issue 4 ,  pages 444

Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris

Billal Tedbirt 1, 2
, 
Estelle Houivet 3
, 
Maud Maho-Vaillant 1, 2
, 
Marie-Laure Golinski 1, 2
, 
Sébastien Calbo 2
, 
Catherine Prost-Squarcioni 4
, 
Bruno Labeille 5
, 
Catherine Picard-Dahan 6
, 
GUILLAUME CHABY 7
, 
Marie-Aleth Richard 8
, 
Emmanuelle Tancrède‐Bohin 9
, 
Sophie Duvert-Lehembre 10, 11
, 
Emmanuel Delaporte 12
, 
Philippe Bernard 13
, 
Frédéric Caux 4
, 
Marina Alexandre 4
, 
Philippe Musette 4
, 
Saskia Ingen-Housz-Oro 14
, 
Pierre Vabres 15
, 
Gaëlle Quereux 16
, 
Alain Dupuy 17
, 
Sébastien Debarbieux 18
, 
Martine Avenel-Audran 19
, 
Michel D'Incan 20
, 
Christophe Bédane 21
, 
Nathalie Bénéton 22
, 
Denis Jullien 23
, 
Nicolas Dupin 24
, 
Laurent Misery 25
, 
Laurent Machet 26
, 
Marie Beylot-Barry 27
, 
Olivier Dereure 28
, 
Bruno Sassolas 29
, 
Nadège Cordel 30
, 
Géraldine Jeudy 31
, 
Jacques Benichou 32
, 
Vivien Hébert 1, 2
, 
Pascal Joly 1, 2
1
 
2
 
3
 
4
 
5
 
6
 
7
 
Department of Dermatology, University of Amiens, Amiens, France | 
8
 
9
 
10
 
11
 
Department of Dermatology, CH Dunkerque, Dunkirk, France | 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
Department of Dermatology, Le Mans General Hospital, Le Mans, France | 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 
31
 
Department of Dermatology, CHU Le Bocage, Dijon, France | 
32
 
Publication type: Journal Article
Publication date: 2025-04-01
American Medical Association (AMA)
scimago Q1
wos Q1
SJR: 2.839
CiteScore: 12.4
Impact factor: 11.0
ISSN: 21686068, 21686084
Abstract

This cohort study examines the safety and efficacy of rituximab for patients with pempigus foliaceus.

Found 
Found 

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
1
Share
Cite this
GOST |
Cite this
GOST Copy
Tedbirt B. et al. Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris // JAMA Dermatology. 2025. Vol. 161. No. 4. p. 444.
GOST all authors (up to 50) Copy
Tedbirt B., Houivet E., Maho-Vaillant M., Golinski M., Calbo S., Prost-Squarcioni C., Labeille B., Picard-Dahan C., CHABY G., Richard M., Tancrède‐Bohin E., Duvert-Lehembre S., Delaporte E., Bernard P., Caux F., Alexandre M., Musette P., Ingen-Housz-Oro S., Vabres P., Quereux G., Dupuy A., Debarbieux S., Avenel-Audran M., D'Incan M., Bédane C., Bénéton N., Jullien D., Dupin N., Misery L., Machet L., Beylot-Barry M., Dereure O., Sassolas B., Cordel N., Jeudy G., Benichou J., Hébert V., Joly P. Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris // JAMA Dermatology. 2025. Vol. 161. No. 4. p. 444.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1001/jamadermatol.2024.6654
UR - https://jamanetwork.com/journals/jamadermatology/fullarticle/2830695
TI - Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris
T2 - JAMA Dermatology
AU - Tedbirt, Billal
AU - Houivet, Estelle
AU - Maho-Vaillant, Maud
AU - Golinski, Marie-Laure
AU - Calbo, Sébastien
AU - Prost-Squarcioni, Catherine
AU - Labeille, Bruno
AU - Picard-Dahan, Catherine
AU - CHABY, GUILLAUME
AU - Richard, Marie-Aleth
AU - Tancrède‐Bohin, Emmanuelle
AU - Duvert-Lehembre, Sophie
AU - Delaporte, Emmanuel
AU - Bernard, Philippe
AU - Caux, Frédéric
AU - Alexandre, Marina
AU - Musette, Philippe
AU - Ingen-Housz-Oro, Saskia
AU - Vabres, Pierre
AU - Quereux, Gaëlle
AU - Dupuy, Alain
AU - Debarbieux, Sébastien
AU - Avenel-Audran, Martine
AU - D'Incan, Michel
AU - Bédane, Christophe
AU - Bénéton, Nathalie
AU - Jullien, Denis
AU - Dupin, Nicolas
AU - Misery, Laurent
AU - Machet, Laurent
AU - Beylot-Barry, Marie
AU - Dereure, Olivier
AU - Sassolas, Bruno
AU - Cordel, Nadège
AU - Jeudy, Géraldine
AU - Benichou, Jacques
AU - Hébert, Vivien
AU - Joly, Pascal
PY - 2025
DA - 2025/04/01
PB - American Medical Association (AMA)
SP - 444
IS - 4
VL - 161
SN - 2168-6068
SN - 2168-6084
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2025_Tedbirt,
author = {Billal Tedbirt and Estelle Houivet and Maud Maho-Vaillant and Marie-Laure Golinski and Sébastien Calbo and Catherine Prost-Squarcioni and Bruno Labeille and Catherine Picard-Dahan and GUILLAUME CHABY and Marie-Aleth Richard and Emmanuelle Tancrède‐Bohin and Sophie Duvert-Lehembre and Emmanuel Delaporte and Philippe Bernard and Frédéric Caux and Marina Alexandre and Philippe Musette and Saskia Ingen-Housz-Oro and Pierre Vabres and Gaëlle Quereux and Alain Dupuy and Sébastien Debarbieux and Martine Avenel-Audran and Michel D'Incan and Christophe Bédane and Nathalie Bénéton and Denis Jullien and Nicolas Dupin and Laurent Misery and Laurent Machet and Marie Beylot-Barry and Olivier Dereure and Bruno Sassolas and Nadège Cordel and Géraldine Jeudy and Jacques Benichou and Vivien Hébert and Pascal Joly},
title = {Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris},
journal = {JAMA Dermatology},
year = {2025},
volume = {161},
publisher = {American Medical Association (AMA)},
month = {apr},
url = {https://jamanetwork.com/journals/jamadermatology/fullarticle/2830695},
number = {4},
pages = {444},
doi = {10.1001/jamadermatol.2024.6654}
}
MLA
Cite this
MLA Copy
Tedbirt, Billal, et al. “Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris.” JAMA Dermatology, vol. 161, no. 4, Apr. 2025, p. 444. https://jamanetwork.com/journals/jamadermatology/fullarticle/2830695.